Review
Published on 14 Feb 2022
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.782199
- 7,224 views
- 19 citations
Type at least 3 characters
594 articles
Articles
Original Research
Published on 11 Feb 2022
Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.819787
- 4,343 views
- 11 citations
Systematic Review
Published on 11 Feb 2022
Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.822178
- 19,243 views
- 14 citations
Original Research
Published on 10 Feb 2022
Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.770863
- 2,857 views
- 13 citations
Original Research
Published on 10 Feb 2022
Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.801094
- 5,734 views
- 21 citations
Review
Published on 10 Feb 2022
Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.800950
- 8,433 views
- 43 citations
Original Research
Published on 07 Feb 2022
Combining Neprilysin Inhibitor With AT2R Agonist Is Superior to Combination With AT1R Blocker in Providing Reno-Protection in Obese Rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.778953
- 2,869 views
- 1 citation
Systematic Review
Published on 07 Feb 2022
Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.819327
- 12,714 views
- 20 citations
Original Research
Published on 04 Feb 2022
Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.817793
- 7,565 views
- 19 citations
Original Research
Published on 31 Jan 2022
SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.707006
- 3,258 views
- 5 citations
Original Research
Published on 28 Jan 2022
Ketamine Induced Bladder Fibrosis Through MTDH/P38 MAPK/EMT Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.743682
- 4,443 views
- 5 citations
Original Research
Published on 28 Jan 2022
The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.804000
- 2,330 views
- 3 citations
Original Research
Published on 27 Jan 2022
Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.792139
- 4,859 views
- 17 citations
Original Research
Published on 25 Jan 2022
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.811836
- 6,008 views
- 9 citations
Review
Published on 25 Jan 2022
Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.820071
- 5,029 views
- 16 citations
Opinion
Published on 24 Jan 2022
Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.751496
- 7,121 views
- 10 citations